Laila Impex Honored in India

VIJAYAWADA, India—Laila Impex was recognized by India’s Department of Scientific & Industrial Research (DSIR), Ministry of Science and Technology, with a national award for outstanding in-house R&D achievements in 2007. Laila was recognized in the chemical and allied industries category for the development and commercialization of 5-LOXIN®, an anti-inflammatory and anti-arthritic ingredient. Laila is an ISO (International Standards Organization)- and GMP (good manufacturing practice)-certified manufacturer, which also operates a nutraceutical and drug discovery research facility.

Rama Raju, president of Laila Impex, said: “5-LOXIN is a unique boswellic acid composition, providing efficacy for joint health, respiratory health and digestive health by inhibiting the 5-lipoxygenase enzyme. This development of an Ayurvedic herb used for millennia allows a more potent, targeted and concentrated material at a critical juncture, providing an alternative to products that inhibit COX-2 enzymes, without the negative health concerns. Thus we can provide a cost-effective solution for people with health concerns, allowing them to return to more productive lives.”

Morristown, N.J.-based P.L. Thomas (PLT) is Laila’s strategic alliance partner in the United States, marketing Laila’s products and technologies. “Laila and PLT have developed the strongest business and friendship ties over the past 20 years,” said PLT’s president, Paul Flowerman. “This award validates the industry-leading R&D work Laila has completed and continues to pursue, including the development of one of the top diet ingredients in the United States, and 5-LOXIN, one of the leading branded ingredients in the joint health category.”